1. Home
  2. FFIC vs CTMX Comparison

FFIC vs CTMX Comparison

Compare FFIC & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FFIC
  • CTMX
  • Stock Information
  • Founded
  • FFIC 1929
  • CTMX 2008
  • Country
  • FFIC United States
  • CTMX United States
  • Employees
  • FFIC N/A
  • CTMX N/A
  • Industry
  • FFIC Major Banks
  • CTMX Biotechnology: Pharmaceutical Preparations
  • Sector
  • FFIC Finance
  • CTMX Health Care
  • Exchange
  • FFIC Nasdaq
  • CTMX Nasdaq
  • Market Cap
  • FFIC 415.1M
  • CTMX 444.3M
  • IPO Year
  • FFIC 1995
  • CTMX 2015
  • Fundamental
  • Price
  • FFIC $11.93
  • CTMX $2.14
  • Analyst Decision
  • FFIC Hold
  • CTMX Strong Buy
  • Analyst Count
  • FFIC 3
  • CTMX 2
  • Target Price
  • FFIC $16.17
  • CTMX $5.00
  • AVG Volume (30 Days)
  • FFIC 175.4K
  • CTMX 3.1M
  • Earning Date
  • FFIC 07-24-2025
  • CTMX 08-07-2025
  • Dividend Yield
  • FFIC 7.44%
  • CTMX N/A
  • EPS Growth
  • FFIC N/A
  • CTMX 128.27
  • EPS
  • FFIC N/A
  • CTMX 0.49
  • Revenue
  • FFIC $124,028,000.00
  • CTMX $147,557,000.00
  • Revenue This Year
  • FFIC $112.30
  • CTMX N/A
  • Revenue Next Year
  • FFIC $7.61
  • CTMX N/A
  • P/E Ratio
  • FFIC N/A
  • CTMX $4.43
  • Revenue Growth
  • FFIC N/A
  • CTMX 23.81
  • 52 Week Low
  • FFIC $10.65
  • CTMX $0.40
  • 52 Week High
  • FFIC $18.59
  • CTMX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • FFIC 48.63
  • CTMX 47.43
  • Support Level
  • FFIC $11.13
  • CTMX $2.08
  • Resistance Level
  • FFIC $12.49
  • CTMX $3.10
  • Average True Range (ATR)
  • FFIC 0.29
  • CTMX 0.26
  • MACD
  • FFIC -0.01
  • CTMX -0.12
  • Stochastic Oscillator
  • FFIC 58.82
  • CTMX 6.37

About FFIC Flushing Financial Corporation

Flushing Financial Corp operates as a bank holding company, which is engaged in the provision of banking and financial services. It provides Personal, Business, lending, Government banking, and Card services. Its principal business is attracting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, in originations and purchases of multi-family residential properties, commercial business loans, commercial real estate mortgage loans, construction loans, small business administration loans, and other small business loans.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: